ArticleNature cancer2026

Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial.

Silvia Marsoni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.